RDN for the Treatment of Influenza in Children: a Randomized, Double-blinded, Parallel-controlled Clinical Trial

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2023 Jul 20

PMID 37474974

Authors

Shuo Yang

Yan-Ming Xie

Lian-Xin Wang

Affiliations

Soon will be listed here.

Abstract

Background: The morbidity of influenza in children increased rapidly in decade. Reduning injection (RDN), a small but fine Chinese herbal formula, has antipyretic, antiviral, anti-inflammatory effects. We intend to evaluate the efficacy and safety of RDN for the influenza in children versus Oseltamivir, explore the possible antiviral mechanism of RDN and provide evidence-based medical evidence for rational clinical drug usage.

Method: We design a randomized, double-blind, double-dummy, parallel control of positive drug, multi-centre clinical study. According to the formula of mean superiority test, a total of 240 patients with influenza in children will be randomized 1:1 into the experimental group and control group. The experimental group will take RDN and Oseltamivir phosphate granule simulants and the control group will take Oseltamivir phosphate granule and RDN simulants. Each group will be treated for 5 days. The primary outcome measure is temperature recovery time, and the secondary outcome measures include time when the fever begins to subside, time and degree of disease to alleviate, disappearance rate of individual symptoms and so on. We will measure before enrollment and each 24 h after treatment for comparison.

Discussion: The study is launched to evaluate the efficacy and safety of RDN for the treatment of influenza in children and to provide an alternative option for influenza in children.

Trial Registration: This study is registered in ClinicalTrials.gov as NCT04183725, registered on 3 December, 2019.

References

Black R, Cousens S, Johnson H, Lawn J, Rudan I, Bassani D . Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010; 375(9730):1969-87. DOI: 10.1016/S0140-6736(10)60549-1. View

Flory J, Emanuel E . Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA. 2004; 292(13):1593-601. DOI: 10.1001/jama.292.13.1593. View

. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator. Ann Med. 1994; 26(2):89-94. DOI: 10.3109/07853899409147334. View

Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T . Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J. 2009; 28(5):372-5. DOI: 10.1097/INF.0b013e318191eef7. View

Jefford M, Moore R . Improvement of informed consent and the quality of consent documents. Lancet Oncol. 2008; 9(5):485-93. DOI: 10.1016/S1470-2045(08)70128-1. View

Chan A, Tetzlaff J, Gotzsche P, Altman D, Mann H, Berlin J . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013; 346:e7586. PMC: 3541470. DOI: 10.1136/bmj.e7586. View

Lyu J, Xie Y, Gao Z, Shen J, Deng Y, Xiang S . Sanjin tablets for acute uncomplicated lower urinary tract infection (syndrome of dampness-heat in the lower jiao): protocol for randomized, double-blind, double-dummy, parallel control of positive drug, multicenter clinical trial. Trials. 2019; 20(1):446. PMC: 6642468. DOI: 10.1186/s13063-019-3539-5. View

Binnicker M, Espy M, Irish C, Vetter E . Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR Assay. J Clin Microbiol. 2015; 53(7):2353-4. PMC: 4473187. DOI: 10.1128/JCM.00791-15. View

Gaitonde D, Moore F, Morgan M . Influenza: Diagnosis and Treatment. Am Fam Physician. 2019; 100(12):751-758. View

10.

Sampson H, Munoz-Furlong A, Campbell R, Adkinson Jr N, Bock S, Branum A . Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117(2):391-7. DOI: 10.1016/j.jaci.2005.12.1303. View

11.

Hu S, Ma R, Shen K, Xin D, Li X, Xu B . Efficacy and safety of Qinxiang Qingjie oral solution for the treatment of influenza in children: a randomized, double-blind, multicenter clinical trial. Transl Pediatr. 2022; 11(6):987-1000. PMC: 9253950. DOI: 10.21037/tp-22-201. View

12.

Liu Y, Mu W, Xiao W, Wei B, Wang L, Liu X . Efficacy and safety of Re-Du-Ning injection in the treatment of seasonal influenza: results from a randomized, double-blinded, multicenter, oseltamivir-controlled trial. Oncotarget. 2017; 8(33):55176-55186. PMC: 5589650. DOI: 10.18632/oncotarget.19220. View

13.

Wang D, Du X . [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring]. Zhongguo Zhong Yao Za Zhi. 2013; 37(18):2686-8. View

14.

Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S . A brief review of influenza virus infection. J Med Virol. 2021; 93(8):4638-4646. DOI: 10.1002/jmv.26990. View

15.

Li Z, Li L, Chen T, Li C, Wang D, Yang Z . Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial. Trials. 2015; 16:126. PMC: 4383212. DOI: 10.1186/s13063-015-0645-x. View

16.

Hu L, Bao X, Wang Q . Methods and analysis of realizing randomized grouping. Zhong Xi Yi Jie He Xue Bao. 2011; 9(7):711-4. DOI: 10.3736/jcim20110703. View

17.

Ruf B, Knuf M . The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr. 2013; 173(3):265-76. PMC: 3930829. DOI: 10.1007/s00431-013-2023-6. View

18.

. Recommendations for Prevention and Control of Influenza in Children, 2016-2017. Pediatrics. 2016; 138(4). DOI: 10.1542/peds.2016-2527. View

19.

Heinonen S, Peltola V, Silvennoinen H, Vahlberg T, Heikkinen T . Signs and symptoms predicting influenza in children: a matched case-control analysis of prospectively collected clinical data. Eur J Clin Microbiol Infect Dis. 2011; 31(7):1569-74. DOI: 10.1007/s10096-011-1479-4. View

20.

Li J, Chen Y, Wang X, Yu H . Influenza-associated disease burden in mainland China: a systematic review and meta-analysis. Sci Rep. 2021; 11(1):2886. PMC: 7859194. DOI: 10.1038/s41598-021-82161-z. View